Aveo stock price target

AVEO Pharmaceuticals Inc., AVEO Quick Chart - (NAS) AVEO ... AVEO Pharma surges 48% on recommendation for European approval of its cancer drug MarketWatch. 08:26 AM ET. AVEO Pharma surges 62% on recommendation for European approval of its cancer drug MarketWatch. Wednesday, March 30, 2016. 08:50 AM ET. Aveo Pharmaceuticals started at outperform with $3 stock price target at FBR & Co. MarketWatch

Based on 1 analyst offering 12 month price targets for AVEO Pharma in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a  3 Wall Street analysts have issued ratings and price targets for AVEO Pharmaceuticals in the last 12 months. Their average twelve-month price target is $14.83,  According to analysts' consensus price target of $14.83, AVEO Pharmaceuticals has a potential upside of 306.4% from its current price of $3.65. Find the latest analyst research for AVEO Pharmaceuticals, Inc. Common Stock ( AVEO) at Nasdaq.com. Analyst price targets provided by TipRanks. AVEO Pharmaceuticals Stock Price Forecast, AVEO stock price prediction. Price target in 14 days: 5.220 USD. The best long-term & short-term AVEO  AVEO Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AVEO updated stock price target summary.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Jan 01, 2010 · AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and AVEO Pharmaceuticals, Inc. (AVEO) Stock Analysis & News ... Get breaking news and analysis on AVEO Pharmaceuticals, Inc. (AVEO) stock, price quote and chart, trading and investing tools. AVEO Pharmaceuticals, Inc. (AVEO) Stock Message Board ... The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is based in Cambridge, Massachusetts. Product pipeline candidates include T ivozanib, F iclatuzumab, AV-203, AV-353 and AV-380. AV-380 (GDF-15 Program) AVEO AVEO Pharmaceuticals, Inc. Stock Quote

Get Aveo Pharmaceuticals Inc (AVEO:NASDAQ) real-time stock quotes, news and financial information from CNBC.

AVEO AVEO Pharmaceuticals, Inc. Stock Quote AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need.

Online Stock Comparison - Compare AVEO Pharmaceuticals, Inc. (AVEO) to four other stocks with NASDAQ.com's stock comparison tool.

See AVEO Pharma price target based on 1 analysts offering 12 month price targets for AVEO Pharma in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 58.73% increase from the last price of $3.78. AVEO Pharmaceuticals Price Target & Analyst Ratings ... Nov 06, 2019 · 2 Wall Street analysts have issued ratings and price targets for AVEO Pharmaceuticals in the last 12 months. Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 180.37%. The high price target for AVEO is … AVEO Stock Price, Forecast & News (AVEO Pharmaceuticals) 3 Wall Street analysts have issued 1-year price objectives for AVEO Pharmaceuticals' stock. Their forecasts range from $6.00 to $20.00. On average, they anticipate AVEO Pharmaceuticals' share price to reach $14.83 in the next year. This suggests a possible upside of 327.5% from the stock's current price.

HC Wainwright restated a “buy” rating and issued a $1.75 price target on shares of AVEO Pharmaceuticals in a research report on Tuesday, October 1st. Piper Jaffray Companies reduced their price target on AVEO Pharmaceuticals from $4.00 to $2.00 and set an “overweight” rating for the company in a research report on Monday, November 4th.

$AVEO upgraded to Buy with a $1.75 (89% upside) price target at H.C. Wainwright. Shares up 4% premarket. Publish. stock  HC Wainwright Reiterates Buy Rating for AVEO Pharmaceuticals $AVEO So analysts seem to be very confident about $AVEO.… https://t.co/5LJyLTj9mi 20 Feb 2020 At the very opening of the session, the stock price was $0.55 and During the last month, 2 analysts gave the AVEO Pharmaceuticals, Inc. a  25 Mar 2020 Analyst Watch: Analysts have assigned their consensus opinion on this (AVEO) stock changed position at 4.20% to closing price of $2.73 in  27 Mar 2020 AVEO Pharmaceuticals stock has been on a good run this week, jumping 60%. In the last Analysts expected a loss of $0.58 per share. AVEO Price Target | AVEO Pharma Stock Forecast & Ratings See AVEO Pharma price target based on 1 analysts offering 12 month price targets for AVEO Pharma in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 58.73% increase from the last price of $3.78.

Find real-time AVEO - Aveo Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. AVEO - Aveo Pharmaceuticals Inc Stock quote - CNNMoney.com Markets AVEO | AVEO Pharmaceuticals Inc. Analyst Estimates ...